Latest News

Fox News - Denver, Colorado“Colorado company wins FDA approval for COVID-19 clinical study”
Click here.

Ampio Reports Positive Results for Ampion Treatment in COVID-19 Patients

Date: September 9, 2020 | READ MORE >

Ampio Announces Enrollment Completion for Intravenous (“IV”) COVID-19 Clinical Trial & Provides Update on Osteoarthritis of the Knee (“OAK”) Clinical Trial

Date: September 4, 2020 | READ MORE >

Ampio Provides Update on COVID-19 Clinical Trial Activities

Date: August 19, 2020 | READ MORE >

Ampio Starts Patient Enrollment in its Ampion COVID-19 Program

Date: July 23, 2020 | READ MORE >

Ampio Reports a Publication on the Potential Benefits of Ampion for Treatment of a New COVID-19 related Syndrome

Date: July 20, 2020 | READ MORE >

Ampio to Start First Clinical Trial in COVID-19 Program

Date: June 19, 2020 | READ MORE >

Ampio Provides Update on COVID-19 Program

Date: May 22, 2020 | READ MORE >

Ampio Reports Acceptance of Publication on the Potential Benefits of Nebulized Ampion™ for COVID-19 Patients

Date: May 11, 2020 | READ MORE >

Ampio Pharmaceutical’s Application to the FDA for a Clinical Study of Ampion to Treat COVID-19 Induced Acute Respiratory Distress Syndrome (ARDS) featured in FOX News (VIDEO)

Date: April 2, 2020 | READ MORE >

Ampio Suspends Patient Enrollment in its Phase 3 Study of Ampion for Severe Osteoarthritis of the Knee and Explores Other Options to Complete Trial

Date: March 24, 2020 | READ MORE >

Ampio is Preparing an Expanded Access FDA protocol to Study Nebulized Ampion as a Treatment for Moderate to Severe Acute Respiratory Distress Syndrome Associated with COVID-19

Date: March 24, 2020 | READ MORE >

Ampio Provides Corporate Update

Date: February 21, 2020 | READ MORE >

Ampio Provides Update on AP-013 Phase III Clinical Trial and Annual Meeting Conference Call Number

Date: December 4, 2019 | READ MORE >

Ampio Provides Update on Continued Progress of AP-013 Phase III Clinical Trial and Manufacturing Facility

Date: October 10, 2019 | READ MORE >

Ampio Retains Legal Counsel for Transaction Advisory Committee

Date: September 18, 2019 | READ MORE >

Ampio Pharmaceuticals Updates Progress of SPA Clinical Trial

Date: September 17, 2019 | READ MORE >

Ampio Pharmaceuticals Retains Financial Advisor and Appoints Transaction Advisory Committee

Date: August 22, 2019 | READ MORE >

Ampio Pharmaceuticals Updates Progress of SPA Clinical Trial

Date: July 25, 2019 | READ MORE >

Ampio Appoints Moss Adams LLP as the Company’s New Independent Auditor

Date: July 11, 2019 | READ MORE >

Ampio Appoints Dan Stokely as the Company’s new Chief Financial Officer

Date: July 10, 2019 | READ MORE >